Holen Sie sich die Stockscreener-App
4.085
2.93%
0.155
Finanzdaten der Cytomx Therapeutics Inc-Aktie (CTMX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-09-30 | 2023-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
63.36%
18.66
|
50.92 | 25.11 | 33.43 | 26.61 |
Operating Expenses
|
29.52%
19.94
|
28.30 | 33.57 | 29.32 | 27.21 |
| Benefits Costs and Expenses |
31.40%
18.75
|
27.33 | 31.60 | 27.64 | 24.70 |
| Costs And Expenses |
31.40%
18.75
|
27.33 | 31.60 | 27.64 | 24.70 |
| Operating Income/Loss |
105.68%
-1.286
|
22.62 | -8.452 | 4.111 | -0.606 |
| Income/Loss From Continuing Operations Before Tax |
100.39%
-0.091
|
23.59 | -6.483 | 5.797 | 1.906 |
| Income Tax Expense/Benefit |
1.61%
0.063
|
0.062 | 0.051 | 0.061 | 1.069 |
| Income/Loss From Continuing Operations After Tax |
100.65%
-0.154
|
23.52 | -6.534 | 5.736 | 0.837 |
|
Net Income/Loss
|
100.65%
-0.154
|
23.52 | -6.534 | 5.736 | 0.837 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
48.16%
129.08
|
87.12 | 84.88 | 85.09 | 2.5828 |
| Diluted Average Shares |
48.11%
129.08
|
87.15 | 84.88 | 85.20 | 2.5828 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.12%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):